Ignite Creation Date:
2024-05-06 @ 7:30 PM
Last Modification Date:
2024-10-26 @ 3:08 PM
Study NCT ID:
NCT06031558
Status:
RECRUITING
Last Update Posted:
2023-09-21
First Post:
2023-08-31
Brief Title:
Phase III Study of SY-5007 a RET Inhibitor in Patients With Locally Advanced or Metastatic RET Fusion-positive NSCLC
Sponsor:
Organization:
Shouyao Holdings Beijing Co LTD